Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03792854 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

Study acronym: LANACARE
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 3, 2019 (before its estimated December 2021 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Observational study to evaluate longitudinal quality of life according to standardized EORTC questionaires as well as functional outcome, oncological outcome and toxicity in patients treated with definitive chemoradiation for anal cancer
Trial Details
NCT Number NCT03792854
Lead Sponsor Ludwig-Maximilians - University of Munich
Conditions
(from sponsor)		 Anal Cancer, Quality of Life, Chemoradiation
Related terms Anus Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov